Blood Test Could Help Identify Sight-Threatening Diabetic Retinopathy

Study supports use of cystatin C as a triage test to prioritize retinal screening in type two diabetes.

East Asian Eyes Develop More DR Lesions

A predominantly peripheral distribution was most common in these patients.

DR, Chronic Kidney Disease Go Hand-in-Hand

Older age and higher body mass index were associated with the latter, and those with a higher fasting glucose level were more likely to have diabetic retinopathy.

DME Eyes Have Poorer Response to Anti-VEGF

Decreased outer retinal thickness was more likely to be present in patients undergoing this therapy.

Nearly Half of All Diabetes Patients Experience Retinopathy

WHO data also documents the connection with predisposing factors such as obesity.

Severe NPDR Progresses Rapidly Without Treatment

Targeted therapy may delay disease progression and help avoid severe vision loss.

DR Risk Prediction Algorithm Determines Follow-up

Nine factors helped decide whether patients with type two diabetes needed to be scheduled for a one-year visit.

Pregnant Diabetic Patients at Higher Risk for DR Progression

Types one and two showed a similar prevalence.

Updated Benchmarks For PDR Complications, Visual Outcomes

Techniques that have modernized since the 2000s have improved patient results.

RNFL Thinning Occurs in Prediabetes, Too

This parameter may be the first sign of retinopathy in these patients.

Upcoming Events

May 24, 2022

Early Identification and Timely Referral
Location: Virtual Event
Speakers: Carolyn Majcher, OD, FAAO, FORS, and Jonathan Jonisch, MD
7:00–8:00pm EST

Sponsored by Regeneron

Register here

June 10-11, 2022

Intrepid Presents: Innovations and Implementations in Practice
Location: Renaissance Newport Beach
Program Co-chairs: Nathan Lighthizer, OD, FAAO and John D. Gelles, OD, FIAO, FCLSA
Earn 14 LIVE COPE Credits (approval pending)

Register here

June 16, 2022

Establishing a Partnership in the Effective Management of Patients with Diabetic Retinal Disease
Location: The Palm Chicago
Speakers: Steven Ferrucci, OD, FAAO, and Dilsher Dhoot, MD
7:30–8:30pm CST

Sponsored by Regeneron

Register here